Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study

The overall hepatic prognosis was comparable between the SGLT2i and the DPP4i groups. Further prospective studies are required to reach robust conclusions.

Authors

Institutions

Publication Details

Journal
Annals of Hepatology
Published
2025-12-22
DOI
https://doi.org/10.1016/j.aohep.2025.102175
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study

Byungyoon Yun, Juyeon Oh, Beom Kyung Kim, Jian Lee et al.
Annals of Hepatology
Liver Disease Diagnosis and Treatment
article

Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study

Byungyoon Yun, Juyeon Oh, Beom Kyung Kim, Jian Lee, Heejoo Park, Jin-Ha Yoon
article en

Abstract

The overall hepatic prognosis was comparable between the SGLT2i and the DPP4i groups. Further prospective studies are required to reach robust conclusions.

Annals of HepatologyVol. 31(1)
Yonsei University (KR), Yonsei University Health System (KR)
Openalex Percentile: Top 31%
Liver Disease Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.